110 HR 4055 IH: To amend title XVIII of the Social Security Act to U.S. House of Representatives 2007-11-01 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I 110th CONGRESS 1st Session H. R. 4055 IN THE HOUSE OF REPRESENTATIVES November 1, 2007 Ms. DeLauro (for herself and Ms. Schwartz) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend title XVIII of the Social Security Act to provide for Medicare coverage of screening tests for human papillomavirus (HPV).

1.

Short title

This Act may be cited as the Medicare Cervical Cancer Screening and Detection Coverage Act of 2007.

2.

Medicare coverage of screening tests for human papillomavirus (HPV)

(a)

In general

Section 1861 of the Social Security Act (42 U.S.C. 1395x) is amended— (1)in subsection (s)(14), by striking smear and screening pelvic exam and inserting test, screening pelvic exam, and screening HPV test; and (2)in subsection (nn)— (A)in the heading, by striking Smear; Screening Pelvic Exam and inserting Test; Screening Pelvic Exam; Screening HPV Test; (B)in paragraph (1), by striking smear and inserting test; (C)in paragraphs (1) and (2), by striking paragraph (3) and inserting paragraph (4); (D)by redesignating paragraph (3) as paragraph (4); and (E)by inserting after paragraph (2) the following new paragraph: (3)(A)The term screening HPV test means a molecular laboratory test for detecting the presence of high-risk human papillomavirus when administered in conjunction with a Pap test if, subject to subparagraph (B), the woman involved has not had such a test during the preceding 3 years or during the preceding year in the case of a woman described in paragraph (4). (B)With respect to coverage of screening HPV tests— (i)the Secretary, in consultation with organizations with expertise in cytopathology, gynecology, and women’s health, shall review the evidence basis and clinical guidelines for the appropriate frequency, age, and such other factors pertinent to such screening HPV tests; and (ii)the Secretary, based upon the review conducted under clause (i) and in consultation with the organizations referred to in clause (i), may revise from time to time the criteria applied under subparagraph (A) for the coverage of screening HPV tests. . (b)

Conforming amendments

(1)

Inclusion in referrals as part of initial preventive physical examination

Section 1861(ww)(2)(C) of such Act (42 U.S.C. 1396x(ww)(2)(C)) is amended by striking smear and screening pelvic exam and inserting test, screening pelvic exam, and screening HPV test. (2)

Waiver of deductible

Section 1833(b)(6) of such Act (42 U.S.C. 1395l(b)(6)) is amended by striking smear and screening pelvic exam and inserting test, screening pelvic exam, and screening HPV test. (3)

Application of pap test payment rule

Section 1833(h)(7) of such Act (42 U.S.C. 1305l(h)(7)) is amended— (A)by striking smear; and (B)by adding at the end the following: Such minimum payment amount shall also apply to payment for screening HPV tests. (4)

Application of pap test frequency limits

Section 1862(a)(1)(F) of such Act (42 U.S.C. 1395y(a)(1)(F)) is amended by striking smear and screening pelvic exam and inserting test, screening pelvic exam, and screening HPV test. (5)

Application of pap test exception under competitive acquisition program

Section 1847(e)(1)(A) of such Act (42 U.S.C. 1395w–3(e)(1)(A)) is amended by striking pap smear laboratory tests and inserting pap tests and screening HPV tests. (c)

Effective date

The amendments made by this section shall apply to services furnished on or after January 1, 2008.